SK Chemicals' self-developed hemophilia treatment Afstyla (Lonoctocog Alfa (blood coagulation factor VIII, genetic recombination) ) finally passed the Health Insurance Policy Committee. It took 15 months after obtaining a domestic permit and one year after applying for insurance registration. The start of benefits was set on June 1, when supply was available, and the price was set at ₩625 per IU.
The MOHW announced that the amendment (draft) of the Pharmaceutical Benefit List and benefit upper limit price table', which provides benefits for Afstyla, was submitted to the agenda of the Health Insurance Policy Committee during the day (30th), and that both deliberation and resolution were passed. . This dru